ACTIVE

Apham

Financial year 2025 · closed on 31/12/2025
Net result
961,3 €
+102.0% YoY
Gross margin
40 k €
+8.3% YoY
Equity
146,4 k €
+0.7% YoY
Workforce
0,5 ETP
-54.5% YoY

What does Apham do?

Apham is a Public limited company incorporated in 1974. Its registered office is in Antwerpen. It employs on average 0,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0414.244.042
Incorporation
28/06/1974
Legal form
Public limited company
Registered office
Antwerpsesteenweg 182
2660 Antwerpen · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Average workforce
0,5 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2025202420232022202120102009200820072006
Income statement
Gross margin40 k €36,9 k €42,9 k €133,7 k €145,2 k €111,2 k €119,3 k €120,8 k €128,4 k €108,4 k €
EBITDA18,1 k €-38,8 k €1,3 k €58,8 k €72,2 k €31,3 k €37,1 k €44,7 k €57,3 k €38,8 k €
Operating result7,8 k €-43,9 k €-833,3 €55 k €66,9 k €16,9 k €22 k €25 k €38 k €20,3 k €
Net result961,3 €-47,3 k €-1,3 k €24,5 k €62,9 k €7,9 k €6,7 k €13,3 k €23 k €10,3 k €
Balance sheet
Equity146,4 k €145,4 k €262,8 k €264,1 k €258,8 k €162,3 k €154,3 k €177,6 k €164,3 k €141,3 k €
Total assets398,3 k €387,4 k €333,4 k €366,2 k €348,3 k €405,2 k €411,6 k €416,5 k €409,4 k €402,1 k €
Cash41,8 k €60,5 k €127,2 k €137,4 k €135,3 k €83,3 k €91,4 k €62,7 k €100 k €79,2 k €
Debts251,9 k €241,9 k €70,6 k €101,4 k €88,6 k €232,2 k €247,9 k €229 k €235,6 k €233,8 k €
Other
Workforce0,5 ETP1,1 ETP1,5 ETP1,5 ETP1,4 ETP1,4 ETP1,4 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 10 ended

Active mandates

De Becker Farmaceutica

Director · since 01 avril 2024 · 1006.778.737

Represented by De BECKER PIETER

Active

Ended mandates

De Becker Farmaceutica

Director · since 01 avril 2024 · 1006.778.737

Represented by Pieter De Becker

Ended
Ann Hameeuw

Managing director · since 30 juin 2022 · until 30 juin 2028

Ended
Luc Megens

Director · since 30 juin 2022 · until 30 juin 2028

Ended
Ann Hameeuw

Director · since 06 juin 2016 · until 06 juin 2022

Ended
At this address

Other companies at this address

CompanyCBE no.
1006.778.737
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date11/06/202625/07/202501/07/202430/06/202329/07/202212/07/2021
General meeting01/06/202602/06/202524/06/202405/06/202330/06/202206/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

20 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202501/06/202611/06/2026DutchPDF
Abridged model31/12/202402/06/202525/07/2025DutchPDF
Micro model31/12/202324/06/202401/07/2024DutchPDF
Micro model31/12/202205/06/202330/06/2023DutchPDF
Micro model31/12/202130/06/202229/07/2022DutchPDF
Micro model31/12/202006/06/202112/07/2021DutchPDF
Micro model31/12/201902/06/202030/06/2020DutchPDF
Micro model31/12/201803/06/201924/06/2019DutchPDF
Micro model31/12/201704/06/201813/06/2018DutchPDF
Micro model31/12/201606/06/201727/06/2017DutchPDF
Abridged model31/12/201506/06/201601/07/2016DutchPDF
Abridged model31/12/201401/06/201523/06/2015DutchPDF
Abridged model31/12/201302/06/201426/08/2014DutchPDF
Abridged model31/12/201203/06/201325/06/2013DutchPDF
Abridged model31/12/201104/06/201226/06/2012DutchPDF
Abridged model31/12/201006/06/201122/06/2011DutchPDF
Abridged model31/12/200907/06/201021/06/2010DutchPDF
Abridged model31/12/200801/06/200930/06/2009DutchPDF
Abridged model31/12/200702/06/200801/07/2008DutchPDF
Abridged model31/12/200604/06/200730/08/2007DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 10 ended

Active mandates

De Becker Farmaceutica

Director · since 01 avril 2024 · 1006.778.737

Represented by De BECKER PIETER

Active

Ended mandates

De Becker Farmaceutica

Director · since 01 avril 2024 · 1006.778.737

Represented by Pieter De Becker

Ended
Ann Hameeuw

Managing director · since 30 juin 2022 · until 30 juin 2028

Ended
Luc Megens

Director · since 30 juin 2022 · until 30 juin 2028

Ended
Ann Hameeuw

Director · since 06 juin 2016 · until 06 juin 2022

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates06/07/2026
    BENOEMING
    PDF
  • Mandates06/05/2024
    ONTSLAG - BENOEMING
    PDF
  • Mandates20/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/01/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares19/06/2018
    KAPITAAL - AANDELEN
    PDF
  • Mandates05/08/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares04/03/2014
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other20/01/2012
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025961,3 €
  2. 2024
    Annual accounts 2024-47,3 k €
  3. 2023
    Annual accounts 2023-1,3 k €
  4. 2022
    Annual accounts 202224,5 k €
  5. 2021
    Annual accounts 202162,9 k €
  6. 2010
    Annual accounts 20107,9 k €
  7. 2009
    Annual accounts 20096,7 k €
  8. 2008
    Annual accounts 200813,3 k €
  9. 2007
    Annual accounts 200723 k €
  10. 2006
    Annual accounts 200610,3 k €
  11. 28/06/1974
    IncorporationPublic limited company